Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.39) by 125.64 percent. This is a 120.41 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $93.88 million which beat the analyst consensus estimate of $88.52 million by 6.05 percent. This is a 33.16 percent increase over sales of $70.50 million the same period last year.